跳至主要内容
临床试验/CTRI/2008/091/000194
CTRI/2008/091/000194已完成2 期

Phase II Trial of Curcumin in Advanced Head and Neck Cancer Treatment

DBT0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
DBT
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with histo-pathological confirmed squamous cell carcinoma of head and neck (oral cavity/ pharynx/ larynx)
  • 2. Patients who have advanced incurable cancer of head and neck region at the initial diagnosis or those who have failed all standard cancer specific treatment including chemotherapy, radiotherapy
  • 3. Patient has signed and dated the informed consent document
  • 4. Patient is willing and able to fully participate for the duration of the study
  • 5. Patient with anticipated life of more than two months on clinical assessment by team members

排除标准

  • 1. Patient is less than 18 years of age
  • 2. Patient is participating in any other study
  • 3. Patient with non-squamous cell cancers
  • 4. Patient who does not comply with assigned treatment protocol
  • 5. Patient with potential behavior and cognitive impairment

研究者

发起方
DBT

相似试验